Robert W. Baird Boosts Longboard Pharmaceuticals (NASDAQ:LBPH) Price Target to $60.00
Longboard Pharmaceuticals (NASDAQ:LBPH – Free Report) had its target price hoisted by Robert W. Baird from $36.00 to $60.00 in a research report report published on Thursday morning, Benzinga reports. They currently have an outperform rating on the stock. Other research analysts have also issued reports about the company. B. Riley upped their price target […]
More Stories
Short Interest in Churchill Capital Corp IX/Cayman (NASDAQ:CCIXU) Drops By 73.0%
Churchill Capital Corp IX/Cayman (NASDAQ:CCIXU – Get Free Report) saw a significant decrease in short interest during the month of...
Direxion Daily TSLA Bull 2X Shares (NASDAQ:TSLL) Shares Gap Up – Here’s What Happened
Direxion Daily TSLA Bull 2X Shares (NASDAQ:TSLL – Get Free Report)’s share price gapped up prior to trading on Wednesday...
Rocket Companies (NYSE:RKT) Shares Gap Down Following Analyst Downgrade
Rocket Companies, Inc. (NYSE:RKT – Get Free Report) shares gapped down before the market opened on Wednesday after Royal Bank...
Invesco BulletShares 2032 Municipal Bond ETF (NASDAQ:BSMW) Short Interest Update
Invesco BulletShares 2032 Municipal Bond ETF (NASDAQ:BSMW – Get Free Report) was the target of a large growth in short...
iShares Total Return Active ETF (NASDAQ:BRTR) Short Interest Down 74.4% in October
iShares Total Return Active ETF (NASDAQ:BRTR – Get Free Report) was the recipient of a large decline in short interest...
Shopify (TSE:SHOP) Downgraded to “Sector Perform” Rating by ATB Capital
Shopify (TSE:SHOP – Get Free Report) was downgraded by equities researchers at ATB Capital from an “outperform” rating to a...